The gender-specific impact of diabetes and myocardial infarction at baseline and during follow-up on mortality from all causes and coronary heart disease

Journal of the American College of Cardiology

Volumn 45, Issue 9, 2005, Pages 1413-1418

  Hu, Gang ^a,b   Jousilahti, Pekka ^a,b   Qiao, Qing ^a,b   Peltonen, Markku ^a,b   Katoh, Shuichi ^a,c   Tuomilehto, Jaakko ^a,b  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CARDIOVASCULAR RISK; COHORT ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; FOLLOW UP; HEART INFARCTION; HIGH RISK PATIENT; HUMAN; INCIDENCE; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RISK ASSESSMENT;

EID: 18144416601     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2005.01.039     Document Type: Article

References (27)

1. S. Wild, G. Roglic, A. Green, R. Sicree, H. King Global prevalence of diabetes estimates for the year 2000 and projections for 2030 Diabetes Care 27 2004 1047 1053
2. W.A. Muller Diabetes mellitus--long time survival J Insur Med 30 1998 17 27
3. S.M. Haffner, S. Lehto, T. Ronnemaa, K. Pyorala, M. Laakso Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction N Engl J Med 339 1998 229 234
4. F.B. Hu, M.J. Stampfer, C.G. Solomon The impact of diabetes mellitus on mortality from all causes and coronary heart disease in women 20 years of follow-up Arch Intern Med 161 2001 1717 1723
5. P.A. Lotufo, J.M. Gaziano, C.U. Chae Diabetes and all-cause and coronary heart disease mortality among U.S. male physicians Arch Intern Med 161 2001 242 247
6. J.M. Evans, J. Wang, A.D. Morris Comparison of cardiovascular risk between patients with type 2 diabetes and those who had had a myocardial infarction cross sectional and cohort studies BMJ 324 2002 939 942
7. S. Natarajan, Y. Liao, G. Cao, S.R. Lipsitz, D.L. McGee Sex differences in risk for coronary heart disease mortality associated with diabetes and established coronary heart disease Arch Intern Med 163 2003 1735 1740
8. A. Becker, G. Bos, F. de Vegt Cardiovascular events in type 2 diabetes comparison with nondiabetic individuals without and with prior cardiovascular disease. 10-year follow-up of the Hoorn study Eur Heart J 24 2003 1406 1413
9. C.D. Lee, A.R. Folsom, J.S. Pankow, F.L. Brancati Cardiovascular events in diabetic and nondiabetic adults with or without history of myocardial infarction Circulation 109 2004 855 860
10. O. Vaccaro, L.E. Eberly, J.D. Neaton, L. Yang, G. Riccardi, J. Stamler Impact of diabetes and previous myocardial infarction on long-term survival 25-year mortality follow-up of primary screenees of the Multiple Risk Factor Intervention trial Arch Intern Med 164 2004 1438 1443
11. E. Vartiainen, P. Jousilahti, G. Alfthan, J. Sundvall, P. Pietinen, P. Puska Cardiovascular risk factor changes in Finland, 1972-1997 Int J Epidemiol 29 2000 49 56
12. WHO MONICA Project Principal Investigators The World Health Organization MONICA project (monitoring trends and determinants in cardiovascular disease) a major international collaboration J Clin Epidemiol 41 1988 105 114
13. M. Mahonen, V. Salomaa, M. Brommels The validity of hospital discharge register data on coronary heart disease in Finland Eur J Epidemiol 13 1997 403 415
14. WHO Study Group on Diabetes Mellitus Diabetes Mellitus Report of a WHO Study Group WHO Technical Report Series No. 727 1985
15. WHO Consultation Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus 1999 World Health Organisation Geneva
16. J. Waterhouse, C. Muir, P. Correa, J. Powell Cancer Incidence in Five Continents 1976 IARC Scientific Publications Lyon, France
17. D.R. Cox Regression models and life tables (with discussion) J Royal Stat Soc B 34 1972 187 220
18. DECODE Study Group Gender difference in all-cause and cardiovascular mortality related to hyperglycaemia and newly-diagnosed diabetes Diabetologia 46 2003 608 617
19. A. Juutilainen, S. Kortelainen, S. Lehto, T. Ronnemaa, K. Pyorala, M. Laakso Gender difference in the impact of type 2 diabetes on coronary heart disease risk Diabetes Care 27 2004 2898 2904
20. I.M. Stratton, A.I. Adler, H.A.W. Neil Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35) prospective observational study BMJ 321 2000 405 412
21. J.D. Curb, S.L. Pressel, J.A. Cutler Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. Systolic Hypertension in the Elderly Program Cooperative Research Group JAMA 276 1996 1886 1892
22. UK Prospective Diabetes Study Group Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes UKPDS 38 BMJ 317 1998 703 713
23. J. Tuomilehto, D. Rastenyte, W.H. Birkenhager Effects of calcium-channel blockade in older patients with diabetes and systolic hypertension. Systolic Hypertension in Europe Trial Investigators N Engl J Med 340 1999 677 684
24. The ALLHAT Officers and Coordinators for the Collaborative Research Group Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack trial (ALLHAT) JAMA 288 2002 2981 2997
25. K. Pyorala, T.R. Pedersen, J. Kjekshus, O. Faergeman, A.G. Olsson, G. Thorgeirsson Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. A subgroup analysis of the Scandinavian Simvastatin Survival study (4S) Diabetes Care 20 1997 614 620
26. Heart Protection Study Collaborative Group MRC/BHF heart protection study of cholesterol lowering with simvastatin in 20,536 high-risk individuals a randomised placebo-controlled trial Lancet 360 2002 7 22
27. R.B. Goldberg, M.J. Mellies, F.M. Sacks Cardiovascular events and their reduction with pravastatin in diabetic and glucose-intolerant myocardial infarction survivors with average cholesterol levels: subgroup analyses in the Cholesterol And Recurrent Events (CARE) trial. The Care Investigators Circulation 98 1998 2513 2519